{
  "author": {
    "name": "Emma Court Robert Langreth John Tozzi",
    "webUrl": "/author/profile/emma-court-robert-langreth-john-tozzi/",
    "description": "",
    "imageLarge": "https://secure.gravatar.com/avatar/f16d6fc2845f417ea0e93a3f2b6cd37d?s=136&d=mm&r=g",
    "estimate": 1,
    "social": [],
    "articles": [
      {
        "uri": "/2020/10/30/covid-continues-to-put-a-damper-on-health-pharma-industries/",
        "title": "COVID continues to put a damper on health, pharma industries",
        "byline": "Emma Court, Robert Langreth, John Tozzi and Riley Griffin",
        "kicker": "Market Insights",
        "prettyDate": "October 30, 2020",
        "timeToRead": "6 minute",
        "image": {
          "uri": "https://images.benefitspro.com/contrib/content/uploads/sites/412/2020/10/covid-19-coronavirus-economy-money-chart-stocks.jpg",
          "width": "0",
          "height": "0"
        },
        "authors": [
          {
            "webUrl": "/author/profile/emma-court-robert-langreth-john-tozzi/",
            "name": "Emma Court, Robert Langreth, John Tozzi"
          },
          {
            "webUrl": "/author/profile/riley-griffin/",
            "name": "Riley Griffin"
          }
        ],
        "kickerNode": [
          {
            "uri": "/market-insights/",
            "sectionName": "Market Insights"
          }
        ],
        "summary": "For drugmakers, the pandemic has squeezed demand for everything from childhood vaccines to smoking-cessation drugs.",
        "body": null
      }
    ]
  }
}